Leader in AI powered Drug Development and Precision Medicine Superior Science and Risk-Sharing Business Models DYNAMIKA, Cloud AI-Powered Platform for Data Management Smart Imaging Strategy to Accelerate Drug Development

NEWS

IAG Successfully Passes ISO13485 Certification Audit

IAG’s solutions follow ISO13485 21 CFR part 11 quality standards.

IAG & Collaborators Present the Latest Data at ACR 2023 #PsA #SSc #OA

IAG’s team will present new data from musculoskeletal research studies.

IAG’s will Attend Jefferies London Healthcare

Join us at Jefferies London Healthcare Conference, 14-16 November 2023.

Image Analysis Group and Ferring Announce Partnership

to advance women’s reproductive health through AI and technology.

Join IAG at UEG Week, Copenhagen, 15-17 Oct, 23

Reach out: imaging.experts@is-grp.com to schedule a meeting at UEG week.

IAG’s Bio-Partnering Team Joins LSX Leaders Nordics Meeting

For media inquiries or to schedule an interview with Dr. Kubassova, contact: olga.kubassova@ia-grp.com

IAG’s Oncology and AI Expert Team join ESMO ’23

Join IAG’s AI oncology team in Madrid October 20-24, 2023.

DAVIX as a Surrogate Outcome Measure for Scleroderma Patients.

The Lancet Rheumatology publishes the data from the prospective study.

VIEWS

Bone Health: New Drugs vs New Tools

The field of bone health is undergoing unprecedented advancements, with novel imaging techniques deployed to take novel platforms through approvals.

Cartilage Repair: Imaging in Treatment Advancements

Critical Role of Imaging is Crucial in Drug Development

Getting approval: the EMA and the FDA

Thinking through drug approval: the FDA and EMA and their requirements.

Imaging Power in Alzheimer’s Disease (AD) Studies

Breakthroughs in AD research and trials rely on accurate imaging and its interpretation.

BioTech Investing in 2022, Jefferies Conference Reflections

The world saw unprecedented growth in healthcare investing in 2021.

The Promise of Precision Oncology

Artificial Intelligence advancing clinical studies.

Power of Radiomics: Can We Predict Treatment Response to Immunotherapy?

Increase the scientific value of clinical trials and accelerate the drug to market process.

If you aim to disrupt an industry, you must be willing to disrupt yourself

Why embracing digital transformation in drug development is the Leader’s’ job.

IAG, Image Analysis Group

IAG brings radiological expertise and artificial intelligence in a meaningful way to imaging processes, accelerating the power and speed of critical decision making within clinical drug development.

DYNAMIKA, IAG’s Cloud Platform 

IAG’s proprietary platform DYNAMIKA supports seamless data collection, real-time image Quality Control, analytics, and data ingestion. DYNAMIKA brings AI / ML into trial process to allow for a fully transparent data management, trial execution control and central review. ISO Certified, GCP, HIPPA, FDA, 21 CFR part 11

Global Client Services: Clinical Trials

IAG’s project, site support and data teams are located in the USA, UK, EU and Asia. We strategically use radiology imaging, AI and technology to accelerate drug development and lower investment risks. Whether you are entering a phase I/II and need early robust efficacy data or preparing a global phase 3 trial, our science, operations and technology teams will work with you to develop the right solution.

Webinars:
Our Publications

Since 2007, over 2000 articles were published to cover scientific discoveries, technology break-throughs and special cases. We list here some critically important papers and abstracts.